{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:43:12Z","timestamp":1776058992722,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing E-Town Cooperation&Development Foundation","award":["YCXJ-JZ-2022-007"],"award-info":[{"award-number":["YCXJ-JZ-2022-007"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270479, U25C2004 and HY2021-1"],"award-info":[{"award-number":["82270479, U25C2004 and HY2021-1"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Beijing Natural Science Foundation","award":["7242084"],"award-info":[{"award-number":["7242084"]}]},{"name":"Innovative Drug Research and Development National Science and Technology Major Project\uff0cPeking University Medicine plus X Pilot Program-Platform Construction Project","award":["2024YXXLHPT010"],"award-info":[{"award-number":["2024YXXLHPT010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-02916-3","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T07:04:51Z","timestamp":1772694291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SiRNA-based inactivation of Angptl3 alleviates high-fat diet-induced MAFLD and atherosclerosis in LDLR-deficient hamsters"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaohong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yungang","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunde","family":"Xian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"2916_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ng814","volume":"30","author":"R Koishi","year":"2002","unstructured":"Koishi R, Ando Y, Ono M, et al. Angptl3 regulates lipid metabolism in mice. Nat Genet. 2002;30:151\u20137. https:\/\/doi.org\/10.1038\/ng814.","journal-title":"Nat Genet"},{"key":"2916_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrendo.2017.119","volume":"13","author":"S Kersten","year":"2017","unstructured":"Kersten S. Angiopoietin-like 3 in lipoprotein metabolism. Nat Rev Endocrinol. 2017;13:731\u20139. https:\/\/doi.org\/10.1038\/nrendo.2017.119.","journal-title":"Nat Rev Endocrinol"},{"key":"2916_CR3","doi-asserted-by":"publisher","first-page":"21344","DOI":"10.1074\/jbc.M213202200","volume":"278","author":"T Inaba","year":"2003","unstructured":"Inaba T, Matsuda M, Shimamura M, et al. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J Biol Chem. 2003;278:21344\u201351. https:\/\/doi.org\/10.1074\/jbc.M213202200.","journal-title":"J Biol Chem"},{"key":"2916_CR4","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1194\/jlr.M300031-JLR200","volume":"44","author":"Y Ando","year":"2003","unstructured":"Ando Y, Shimizugawa T, Takeshita S, et al. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice. J Lipid Res. 2003;44:1216\u201323. https:\/\/doi.org\/10.1194\/jlr.M300031-JLR200.","journal-title":"J Lipid Res"},{"key":"2916_CR5","doi-asserted-by":"publisher","first-page":"17281","DOI":"10.1074\/jbc.M109768200","volume":"277","author":"G Camenisch","year":"2002","unstructured":"Camenisch G, Pisabarro MT, Sherman D, et al. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem. 2002;277:17281\u201390. https:\/\/doi.org\/10.1074\/jbc.M109768200.","journal-title":"J Biol Chem"},{"key":"2916_CR6","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","volume":"363","author":"K Musunuru","year":"2010","unstructured":"Musunuru K, Pirruccello JP, Do R, et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med. 2010;363:2220\u20137. https:\/\/doi.org\/10.1056\/NEJMoa1002926.","journal-title":"N Engl J Med"},{"key":"2916_CR7","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.jacc.2017.02.030","volume":"69","author":"NO Stitziel","year":"2017","unstructured":"Stitziel NO, Khera AV, Wang X, et al. ANGPTL3 deficiency and protection against coronary artery disease. J Am Coll Cardiol. 2017;69:2054\u201363. https:\/\/doi.org\/10.1016\/j.jacc.2017.02.030.","journal-title":"J Am Coll Cardiol"},{"key":"2916_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa2004215","volume":"383","author":"FJ Raal","year":"2020","unstructured":"Raal FJ, Rosenson RS, Reeskamp LF, et al. Evinacumab for Homozygous Familial Hypercholesterolemia. N Engl J Med. 2020;383:711\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2004215.","journal-title":"N Engl J Med"},{"key":"2916_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1701329","volume":"377","author":"MJ Graham","year":"2017","unstructured":"Graham MJ, Lee RG, Brandt TA, et al. Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides. N Engl J Med. 2017;377:222\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1701329.","journal-title":"N Engl J Med"},{"key":"2916_CR10","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1093\/eurheartj\/ehaa689","volume":"41","author":"D Gaudet","year":"2020","unstructured":"Gaudet D, Karwatowska-Prokopczuk E, Baum SJ, et al. Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia. Eur Heart J. 2020;41:3936\u201345. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa689.","journal-title":"Eur Heart J"},{"key":"2916_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021;50:101238. https:\/\/doi.org\/10.1016\/j.molmet.2021.101238.","journal-title":"Mol Metab"},{"key":"2916_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7:851\u201361. https:\/\/doi.org\/10.1016\/S2468-1253(22)00165-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"Suppl","key":"2916_CR13","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","volume":"29","author":"ML Teng","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29(Suppl):S32\u201342. https:\/\/doi.org\/10.3350\/cmh.2022.0365.","journal-title":"Clin Mol Hepatol"},{"key":"2916_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejim.2023.11.012","volume":"122","author":"A Mellemkj\u00e6r","year":"2024","unstructured":"Mellemkj\u00e6r A, Kj\u00e6r MB, Haldrup D, et al. Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease. Eur J Intern Med. 2024;122:28\u201334. https:\/\/doi.org\/10.1016\/j.ejim.2023.11.012.","journal-title":"Eur J Intern Med"},{"key":"2916_CR15","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/liv.14554","volume":"40","author":"I Barchetta","year":"2020","unstructured":"Barchetta I, Cimini FA, Chiappetta C, et al. Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity. Liver Int. 2020;40:2139\u201347. https:\/\/doi.org\/10.1111\/liv.14554.","journal-title":"Liver Int"},{"key":"2916_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/cr.2014.2","volume":"24","author":"M Gao","year":"2014","unstructured":"Gao M, Zhang B, Liu J, et al. Generation of transgenic golden Syrian hamsters. Cell Res. 2014;24:380\u20132. https:\/\/doi.org\/10.1038\/cr.2014.2.","journal-title":"Cell Res"},{"key":"2916_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ebiom.2017.12.013","volume":"27","author":"X Guo","year":"2018","unstructured":"Guo X, Gao M, Wang Y, et al. LDL receptor gene-ablated hamsters: a rodent model of familial hypercholesterolemia with dominant inheritance and diet-induced coronary atherosclerosis. EBioMedicine. 2018;27:214\u201324. https:\/\/doi.org\/10.1016\/j.ebiom.2017.12.013.","journal-title":"EBioMedicine"},{"key":"2916_CR18","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.7150\/thno.105782","volume":"15","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Chen M, Xu Y, et al. A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY. Theranostics. 2025;15:4325\u201344. https:\/\/doi.org\/10.7150\/thno.105782.","journal-title":"Theranostics"},{"key":"2916_CR19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.104437","volume":"13","author":"X Xian","year":"2024","unstructured":"Xian X, Ding Y, Dieckmann M, et al. LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis. Elife. 2024;13:e104437. https:\/\/doi.org\/10.7554\/eLife.104437.","journal-title":"Elife"},{"key":"2916_CR20","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.7150\/thno.91084","volume":"14","author":"J Guo","year":"2024","unstructured":"Guo J, Miao G, Zhang W, et al. Depletion of ApoA5 aggravates spontaneous and diet-induced nonalcoholic fatty liver disease by reducing hepatic NR1D1 in hamsters. Theranostics. 2024;14:2036\u201357. https:\/\/doi.org\/10.7150\/thno.91084.","journal-title":"Theranostics"},{"key":"2916_CR21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI166149","volume":"134","author":"S Xu","year":"2024","unstructured":"Xu S, Wu X, Wang S, et al. TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase. J Clin Invest. 2024;134:e166149. https:\/\/doi.org\/10.1172\/JCI166149.","journal-title":"J Clin Invest"},{"key":"2916_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-025-00594-3","volume":"12","author":"GL Miao","year":"2025","unstructured":"Miao GL, Zhang WX, Xu YT, et al. Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease. Mil Med Res. 2025;12:11. https:\/\/doi.org\/10.1186\/s40779-025-00594-3.","journal-title":"Mil Med Res"},{"key":"2916_CR23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.015002","volume":"296","author":"H Peng","year":"2021","unstructured":"Peng H, Chiu TY, Liang YJ, et al. PRAP1 is a novel lipid-binding protein that promotes lipid absorption by facilitating MTTP-mediated lipid transport. J Biol Chem. 2021;296:100052. https:\/\/doi.org\/10.1074\/jbc.RA120.015002.","journal-title":"J Biol Chem"},{"issue":"2","key":"2916_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/nu14020251","volume":"14","author":"Z Xu","year":"2022","unstructured":"Xu Z, Qin Y, Lv B, Tian Z, Zhang B. Intermittent fasting improves high-fat diet-induced obesity cardiomyopathy via alleviating lipid deposition and apoptosis and decreasing m6A methylation in the heart. Nutrients. 2022;14(2):251. https:\/\/doi.org\/10.3390\/nu14020251.","journal-title":"Nutrients"},{"issue":"1","key":"2916_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12964-022-00849-9","volume":"20","author":"Y Miao","year":"2022","unstructured":"Miao Y, Zhang C, Yang L, et al. The activation of PPARgamma enhances Treg responses through up-regulating CD36\/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of TbetaRII\/IL-2Ralpha. Cell Commun Signal. 2022;20(1):48. https:\/\/doi.org\/10.1186\/s12964-022-00849-9.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"2916_CR26","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1007\/s11357-024-01153-9","volume":"46","author":"D Kucsera","year":"2024","unstructured":"Kucsera D, Ruppert M, Sayour NV, et al. NASH triggers cardiometabolic HFpEF in aging mice. Geroscience. 2024;46(5):4517\u201331. https:\/\/doi.org\/10.1007\/s11357-024-01153-9.","journal-title":"Geroscience"},{"key":"2916_CR27","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1172\/JCI117179","volume":"93","author":"S Ishibashi","year":"1994","unstructured":"Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest. 1994;93:1885\u201393. https:\/\/doi.org\/10.1172\/JCI117179.","journal-title":"J Clin Invest"},{"key":"2916_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.738060","volume":"8","author":"X Lin","year":"2021","unstructured":"Lin X, Ma P, Yang C, Wang J, et al. Dietary-induced elevations of triglyceride-rich lipoproteins promote atherosclerosis in the low-density lipoprotein receptor knockout Syrian Golden Hamster. Front Cardiovasc Med. 2021;8:738060. https:\/\/doi.org\/10.3389\/fcvm.2021.738060.","journal-title":"Front Cardiovasc Med"},{"key":"2916_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1485801","volume":"16","author":"G Araujo","year":"2025","unstructured":"Araujo G, Valencia LM, Martin-Ozimek A, Soto Y, Proctor SD. Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins. Front Immunol. 2025;16:1485801. https:\/\/doi.org\/10.3389\/fimmu.2025.1485801.","journal-title":"Front Immunol"},{"key":"2916_CR30","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1161\/ATVBAHA.120.315639","volume":"41","author":"M\u00d8 Johansen","year":"2021","unstructured":"Johansen M\u00d8, Vedel-Krogh S, Nielsen SF, Afzal S, Davey Smith G, Nordestgaard BG. Per-particle triglyceride-rich lipoproteins imply higher myocardial infarction risk than low-density lipoproteins: Copenhagen general population study. Arterioscler Thromb Vasc Biol. 2021;41:2063\u201375. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315639.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2916_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-016-0450-1","volume":"15","author":"D Zhao","year":"2016","unstructured":"Zhao D, Yang LY, Wang XH, et al. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients. Cardiovasc Diabetol. 2016;15:132. https:\/\/doi.org\/10.1186\/s12933-016-0450-1.","journal-title":"Cardiovasc Diabetol"},{"key":"2916_CR32","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/ATVBAHA.113.301397","volume":"33","author":"MR Robciuc","year":"2013","unstructured":"Robciuc MR, Maranghi M, Lahikainen A, et al. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Arterioscler Thromb Vasc Biol. 2013;33:1706\u201313. https:\/\/doi.org\/10.1161\/ATVBAHA.113.301397.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2916_CR33","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/s0006-291x(02)03058-9","volume":"301","author":"M Shimamura","year":"2003","unstructured":"Shimamura M, Matsuda M, Kobayashi S, et al. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem Biophys Res Commun. 2003;301:604. https:\/\/doi.org\/10.1016\/s0006-291x(02)03058-9.","journal-title":"Biochem Biophys Res Commun"},{"key":"2916_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-2003-41284","volume":"111","author":"U Julius","year":"2003","unstructured":"Julius U. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Exp Clin Endocrinol Diabetes. 2003;111:246. https:\/\/doi.org\/10.1055\/s-2003-41284.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2916_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084300","volume":"23","author":"JK Huang","year":"2022","unstructured":"Huang JK, Lee HC. Emerging evidence of pathological roles of very-low-density lipoprotein (VLDL). Int J Mol Sci. 2022;23:4300. https:\/\/doi.org\/10.3390\/ijms23084300.","journal-title":"Int J Mol Sci"},{"key":"2916_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01666-y","volume":"22","author":"M Peyman","year":"2024","unstructured":"Peyman M, Babin-Ebell A, Rodr\u00edguez-Rodr\u00edguez R, et al. SIRT1 regulates hepatic vldlr levels. Cell Commun Signal. 2024;22:297. https:\/\/doi.org\/10.1186\/s12964-024-01666-y.","journal-title":"Cell Commun Signal"},{"key":"2916_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jare.2024.05.011","volume":"70","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Yan C, Dong Y, et al. ANGPTL3 accelerates atherosclerotic progression via direct regulation of M1macrophageactivationinplaque. J Adv Res. 2025;70:125\u201338. https:\/\/doi.org\/10.1016\/j.jare.2024.05.011.","journal-title":"J Adv Res"},{"key":"2916_CR38","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1194\/jlr.RA120000888","volume":"61","author":"RC Adam","year":"2020","unstructured":"Adam RC, Mintah IJ, Alexa-Braun CA, et al. Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase- dependent VLDL clearance. J Lipid Res. 2020;61:1271\u201386. https:\/\/doi.org\/10.1194\/jlr.RA120000888.","journal-title":"J Lipid Res"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02916-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02916-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02916-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:47:38Z","timestamp":1776055658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02916-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2916"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02916-3","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal protocol was approved by the Ethics Committee of Peking University Health Science Center (Beijing, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}